BRPI1010243A2 - derivados de benzotiazinas, preparação dos mesmos e aplicação dos mesmos como fármacos - Google Patents
derivados de benzotiazinas, preparação dos mesmos e aplicação dos mesmos como fármacosInfo
- Publication number
- BRPI1010243A2 BRPI1010243A2 BRPI1010243A BRPI1010243A BRPI1010243A2 BR PI1010243 A2 BRPI1010243 A2 BR PI1010243A2 BR PI1010243 A BRPI1010243 A BR PI1010243A BR PI1010243 A BRPI1010243 A BR PI1010243A BR PI1010243 A2 BRPI1010243 A2 BR PI1010243A2
- Authority
- BR
- Brazil
- Prior art keywords
- drugs
- preparation
- application
- benzothiazine derivatives
- benzothiazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0951336A FR2942797B1 (fr) | 2009-03-03 | 2009-03-03 | Derives de benzothiazines, leur preparation et leur application a titre de medicaments |
| PCT/EP2010/052609 WO2010100139A1 (en) | 2009-03-03 | 2010-03-02 | Derivatives of benzothiazines, preparation thereof and application thereof as drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1010243A2 true BRPI1010243A2 (pt) | 2016-03-22 |
Family
ID=40790339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1010243A BRPI1010243A2 (pt) | 2009-03-03 | 2010-03-02 | derivados de benzotiazinas, preparação dos mesmos e aplicação dos mesmos como fármacos |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US9187438B2 (pt) |
| EP (1) | EP2403840B1 (pt) |
| JP (1) | JP5650139B2 (pt) |
| KR (1) | KR101701531B1 (pt) |
| CN (1) | CN102341379B (pt) |
| AR (1) | AR075777A1 (pt) |
| AU (1) | AU2010220335B2 (pt) |
| BR (1) | BRPI1010243A2 (pt) |
| CA (1) | CA2753630C (pt) |
| CL (1) | CL2011002171A1 (pt) |
| CO (1) | CO6501175A2 (pt) |
| ES (1) | ES2483516T3 (pt) |
| FR (1) | FR2942797B1 (pt) |
| GE (1) | GEP20135832B (pt) |
| IL (1) | IL214907A (pt) |
| MA (1) | MA33138B1 (pt) |
| MX (1) | MX2011008942A (pt) |
| MY (1) | MY160819A (pt) |
| NZ (1) | NZ595276A (pt) |
| PL (1) | PL2403840T3 (pt) |
| RU (1) | RU2523791C2 (pt) |
| SA (1) | SA110310181B1 (pt) |
| SG (1) | SG174208A1 (pt) |
| TN (1) | TN2011000429A1 (pt) |
| TW (1) | TWI495636B (pt) |
| UA (1) | UA105040C2 (pt) |
| WO (1) | WO2010100139A1 (pt) |
| ZA (1) | ZA201107104B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2350077B1 (es) | 2009-06-04 | 2011-11-04 | Laboratorios Salvat, S.A. | Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1. |
| CN103275035B (zh) * | 2013-06-28 | 2014-11-26 | 安徽中医学院 | 苯并噻嗪类化合物、其制备方法及其抗肿瘤用途 |
| CN103271923B (zh) * | 2013-06-28 | 2014-11-26 | 安徽中医学院 | 一种苯并噻嗪衍生物的医药用途 |
| CN103304513B (zh) * | 2013-06-28 | 2015-02-04 | 安徽中医学院 | 一类1,2-苯并噻嗪类化合物、制备方法及其应用 |
| FR3035326B1 (fr) * | 2015-04-21 | 2017-05-12 | Pf Medicament | Utilisation de la (4-hydroxy-2-methyl-1,1-dioxido-2h-benzo[e][1,2]thiazin-3-yl)(naphtalen-2-yl)methanone dans la prevention et/ou le traitement de la steatohepatite non-alcoolique |
| CN106243046B (zh) * | 2016-08-02 | 2019-07-05 | 南京工业大学 | 一种甲基二磺隆的制备方法 |
| KR102652866B1 (ko) | 2017-04-06 | 2024-04-02 | 엥방티바 | Ｙａｐ/ｔａｚ-ｔｅａｄ 상호작용의 억제제인 신규 화합물 및 악성 중피종의 치료에서의 이들의 용도 |
| EP3632908A1 (en) | 2018-10-02 | 2020-04-08 | Inventiva | Inhibitors of the yap/taz-tead interaction and their use in the treatment of cancer |
| WO2023154412A1 (en) * | 2022-02-12 | 2023-08-17 | Miralogx Llc | Anti-inflammatory compounds, pharmaceutical compositions, and treatment methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3591584A (en) * | 1968-08-27 | 1971-07-06 | Pfizer | Benzothiazine dioxides |
| US3808205A (en) * | 1971-09-10 | 1974-04-30 | Warner Lambert Co | Process for the preparation of 4-hydroxy-3-carbamyl-2h-1,2-benzothiazine 1,1-dioxides and 4-hydroxy-3(2h)-1,2-benzothiazine carboxylate-1,1-dioxides |
| US4289879A (en) * | 1980-09-29 | 1981-09-15 | Pfizer Inc. | Synthetic method and intermediate for piroxicam |
| FR2694295B1 (fr) * | 1992-07-28 | 1994-09-02 | Adir | Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5599811A (en) * | 1995-02-21 | 1997-02-04 | Warner-Lambert Company | Benzothiazine dioxides as endothelin antagonists |
| AU2002212672A1 (en) * | 2000-10-12 | 2002-04-22 | Dr. Reddy's Research Foundation | Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them |
| GB0224830D0 (en) * | 2002-10-24 | 2002-12-04 | Sterix Ltd | Compound |
| JP2006522747A (ja) * | 2003-04-11 | 2006-10-05 | ノボ ノルディスク アクティーゼルスカブ | 縮合１，２，４−トリアゾールの薬学的使用 |
| PL372356A1 (pl) * | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| JP5036722B2 (ja) * | 2005-10-20 | 2012-09-26 | メルク・シャープ・エンド・ドーム・コーポレイション | １１−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−１阻害剤としてのトリアゾール誘導体 |
| WO2007058346A1 (ja) * | 2005-11-21 | 2007-05-24 | Shionogi & Co., Ltd. | I型11βヒドロキシステロイド脱水素酵素阻害活性を有するヘテロ環化合物 |
| JP2007197369A (ja) * | 2006-01-26 | 2007-08-09 | Sankyo Co Ltd | ベンゾチアジン誘導体 |
-
2009
- 2009-03-03 FR FR0951336A patent/FR2942797B1/fr not_active Expired - Fee Related
-
2010
- 2010-03-02 AR ARP100100618A patent/AR075777A1/es active IP Right Grant
- 2010-03-02 ES ES10706624.3T patent/ES2483516T3/es active Active
- 2010-03-02 JP JP2011552415A patent/JP5650139B2/ja not_active Expired - Fee Related
- 2010-03-02 UA UAA201111590A patent/UA105040C2/uk unknown
- 2010-03-02 SG SG2011063146A patent/SG174208A1/en unknown
- 2010-03-02 WO PCT/EP2010/052609 patent/WO2010100139A1/en not_active Ceased
- 2010-03-02 EP EP10706624.3A patent/EP2403840B1/en active Active
- 2010-03-02 MY MYPI2011004096A patent/MY160819A/en unknown
- 2010-03-02 US US13/254,473 patent/US9187438B2/en not_active Expired - Fee Related
- 2010-03-02 MX MX2011008942A patent/MX2011008942A/es active IP Right Grant
- 2010-03-02 RU RU2011139014/04A patent/RU2523791C2/ru not_active IP Right Cessation
- 2010-03-02 SA SA110310181A patent/SA110310181B1/ar unknown
- 2010-03-02 NZ NZ595276A patent/NZ595276A/xx not_active IP Right Cessation
- 2010-03-02 KR KR1020117022812A patent/KR101701531B1/ko not_active Expired - Fee Related
- 2010-03-02 PL PL10706624T patent/PL2403840T3/pl unknown
- 2010-03-02 BR BRPI1010243A patent/BRPI1010243A2/pt not_active Application Discontinuation
- 2010-03-02 AU AU2010220335A patent/AU2010220335B2/en not_active Ceased
- 2010-03-02 CA CA2753630A patent/CA2753630C/en not_active Expired - Fee Related
- 2010-03-02 CN CN201080010207.7A patent/CN102341379B/zh not_active Expired - Fee Related
- 2010-03-02 MA MA34191A patent/MA33138B1/fr unknown
- 2010-03-02 GE GEAP201012398A patent/GEP20135832B/en unknown
- 2010-03-03 TW TW099106123A patent/TWI495636B/zh not_active IP Right Cessation
-
2011
- 2011-08-19 TN TN2011000429A patent/TN2011000429A1/fr unknown
- 2011-08-31 IL IL214907A patent/IL214907A/en active IP Right Grant
- 2011-09-02 CL CL2011002171A patent/CL2011002171A1/es unknown
- 2011-09-29 CO CO11128125A patent/CO6501175A2/es active IP Right Grant
- 2011-09-29 ZA ZA2011/07104A patent/ZA201107104B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0920927A2 (pt) | derivados de azaquinolinona e usos dos mesmos | |
| BRPI1009324A2 (pt) | compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos | |
| BR112013011968A2 (pt) | composição farmacêutica, métodos de tratamento e usos da mesma | |
| BR112012006404A2 (pt) | derivados de di-hidropteridinona, processo de preparação e uso farmacêutico dos mesmos | |
| BR112012003709A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
| BRPI1008661A2 (pt) | derivados e remédios de aminopirazina | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| FR2949470B1 (fr) | Derives anticancereux, leur preparation et leur application therapeutique | |
| PT3109248T (pt) | Derivados de heteroarilpiperidina e piperazina como fungicidas | |
| FR2953520B1 (fr) | Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique | |
| BR112013015592A8 (pt) | derivados de biciclo-[3.2.1]-octilamida e usos dos mesmos | |
| BRPI1013246A2 (pt) | derivados de benzofuralina | |
| BR112012002828A2 (pt) | derivados de 5-fluorpirimidinona | |
| BRPI1016117A8 (pt) | derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
| BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
| BR112012001260A2 (pt) | conjugados de epsilon-polilisina e o emprego dos mesmos | |
| DK3360575T3 (da) | Transdermale farmaceutiske sammensætninger omfattende aktive stoffer | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| BR112012003842A2 (pt) | composição farmacêutica, método de formulação e uso da mesma | |
| BRPI1013844A2 (pt) | derivados de piridina-isoxazol | |
| FR2933700B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| BR112012010242A2 (pt) | derivados de heteroarilpiperidina e heteroarilpiperazina | |
| DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
| BRPI1005433A2 (pt) | preparações farmacêuticas transdérmicas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |